Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes™ series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyes™ interface, compose an essential platform for every preclinical laboratory.
Oncology
Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.
Infection, Inflammation
Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.
Protocol optimization
Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.
Quick insights
Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.
Applications with eyes™
Planar imaging
Extending SPECT workflows with fast planar imaging
Fast whole-body planar imaging for rapid assessment of radiopharmaceutical distribution and early kinetics across a broad range of radionuclides
Image info: ⁹⁹ᵐTc-labelled GRPR-targeting peptide in a PC-3 xenograft model - 0-60 min post injection - down to 10 sec frames - 30 MBq injected activity
Study performed in collaboration with the Radiopharmaceutical Chemistry Group at INRASTES, NCSR "Demokritos" (Dr. Ioannis Pirmetttis) and NuclearPharm
Theranostics
Evaluation of preclinical quantitative imaging of ¹¹¹Ag
Optimization and validation in a mouse phantom
Study was conducted in collaboration with Mattia Asti and the AUSL-IRCCS Reggio Emilia research team.